Raishay Lin joined Ropes & Gray’s litigation department in 2016. Her practice focuses on complex civil litigation and government enforcement, particularly for health care and life sciences clients. Raishay has experience in a variety of antitrust matters, including transaction risk counseling, merger review investigations, and class action litigation.
Raishay maintains an active pro bono practice. She has assisted in drafting numerous briefs at the district court level to defend the Deferred Action for Childhood Arrivals (DACA) policy, as well as amicus curiae briefs in the U.S. Supreme Court on behalf of DACA recipients, LGBT individuals, and criminal defendants.
During law school, Raishay interned at the U.S. Attorney’s Office for the District of Maryland and in the Antitrust & Government Fraud department of the Office of the Connecticut Attorney General.
- Advising clients on advocacy and merger review processes before the DOJ, FTC, and state regulators.
- Assisting Independent Compliance Monitor appointed by the DOJ and SEC pursuant to deferred prosecution agreement.
- Representing clients facing antitrust and shareholder class action claims in trial and appellate courts.
- Represented hospital client in strategic acquisition, which cleared regulatory review by the FTC without the issuance of a Second Request.
- Represented pharmaceutical client in successful appeal of an FDA administrative decision.
- Counseled pharmaceutical clients on changing regulations and active litigation regarding state drug price reporting laws.
- Co-author, “The New Class Action Frontier Under Illinois Privacy Law,” Law360 (January 16, 2020)
- Co-author, “The Future of Antitrust Claims at the ITC,” Law360 (May 15, 2018)
- JD, Harvard Law School, 2016; Managing Editor, Harvard Negotiation Law Review
- BA (English), magna cum laude, University of Maryland, 2013; University Medalist; Banneker-Key Scholar